Karolinska Development AB: First Patient Dosed in the Phase I/II Study of Umecrine Mood's Candidate Drug for Premenstrual Dysphoric Disorder
5/23/2013 10:52:45 AM
More...
|
Karolinska Development AB - Interim Report January - March 2013
5/10/2013 9:38:37 AM
More...
|
Karolinska Development AB (publ) - Interim Report January - March 2013
5/10/2013 8:00:09 AM
More...
|
Karolinska Development AB - Interim Report January - March, Invitation to Conference Call Friday, May 10
5/7/2013 9:49:50 AM
More...
|
Karolinska Development AB: Pergamum Announces Last Visit of Last Patient in a Phase I/II Trial of a Potential New Treatment for Hard-to-Heal Wounds
4/19/2013 11:24:23 AM
More...
|
Karolinska Development AB's Annual Report 2012 Has Been Published
4/12/2013 9:49:09 AM
More...
|
Karolinska Development AB and Rosetta Capital Announce the Closing of $34 Million
3/8/2013 10:24:24 AM
More...
|
Karolinska Development AB Signs Agreement With Mayo Clinic
2/4/2013 10:12:07 AM
More...
|
Karolinska Development AB Announces a $33 Million Strategic Deal
12/21/2012 7:10:22 AM
More...
|
Aprea Announces Positive Data From a Clinical Phase I/II Study With APR-246 in Patients With Advanced Cancers
9/18/2012 6:29:33 AM
More...
|
|